[1] SKALOVA A,VANECEK T,SIMA R,et al.Mammary analogue secretory carcinoma of salivary glands,containing the ETV6-NTRK3 fusion gene:a hitherto undescribed salivary gland tumor entity[J].The American Journal of Surgical Pathology,2010,34(5):599-608.
[2] LIAO H,KHAN A,MIRON PM,et al.Mammary analogue secretory carcinoma of the thyroid mimicking locally advanced papillary thyroid carcinoma:a rare case report[J].International Journal of Surgical Pathology,2018,26(5):459-463.
[3] LLAMAS-VELASCO M,MENTZEL T,RUTTEN A.Primary cutaneous secretory carcinoma:a previously overlooked low-grade sweat gland carcinoma[J].Journal of Cutaneous Pathology,2018,45(3):240-245.
[4] HUANG T,MCHUGH JB,BERRY GJ,et al.Primary mammary analogue secretory carcinoma of the lung:a case report[J].Human Pathology,2018,74:109-113.
[5] WU B,LOH TKS,VANECEK T,et al.(mammary analogue) secretory carcinoma of the nasal cavity:report of a rare case with p63 and DOG1 expression and uncommon exon 4-exon 14 ETV6-NTRK3 fusion diagnosed with next generation sequencing[J].Head and Neck Pathology,2020,14(2):542-549.
[6] DING AA,ZUO J,LV H,et al.Imaging identification of primary mammary analogue secretory carcinoma and acinic cell carcinoma in major salivary glands[J].Oral Diseases,2022,28(7):1861-1870.
[7] URANO M,NAGAO T,MIYABE S,et al.Characterization of mammary analogue secretory carcinoma of the salivary gland:discriminationfrom its mimics by the presence of the ETV6-NTRK3 translocationand novel surrogate markers[J].Hum Pathol,2015,46(1):94-103.
[8]BOON E,VALSTAR MH,VAN DER GRAAF WTA,et al.Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands[J].Oral Oncology,2018,82:29-33.
[9] 黄海建,陈小岩.唾液腺分泌性癌9例临床病理,免疫表型及分子遗传学分析[J].临床与实验病理学杂志,2020,36(12):1422-1426.
HUANG HJ,CHEN XY.Clinicopathologic,immunophenotypic and molecular genetic analysis of nine cases of salivary gland secretory carcinoma[J].Journal of Clinical and Experimental Pathology,2020,36(12):1422-1426.
[10] SKALOVA A,VANECEK T,MARTINEK P,et al.Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation[J].The American Journal of Surgical Pathology,2018,42(2):234-246.
[11] SKAUGEN JM,SEETHALA RR,CHIOSEA SI,et al.Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma[J].Cancer Cytopathology,2021,129(2):104-113.
[12] KHOTSKAYA YB,HOLLA VR,FARAGO AF,et al.Targeting TRK family proteins in cancer[J].Pharmacology & Therapeutics,2017,173:58-66.
[13] HONG DS,DUBOIS SG,KUMMAR S,et al.Larotrectinib in patients with TRK fusion-positive solid tumours:a pooled analysis of three phase 1/2 clinical trials[J].The Lancet Oncology,2020,21(4):531-540.
[14] LASSEN U.How I treat NTRK gene fusion-positive cancers[J].ESMO Open,2019,4:e000612.
[15]杨红,覃胜,郭鹏,等.伴高级别转化的涎腺分泌性癌1例并文献复习[J].临床与实验病理学杂志,2023,39(02):236-238,241.
YANG H,QIN S,GUO P,et al.A case of secretory carcinoma of salivary gland with high-grade transformation and literature review[J].Journal of Clinical and Experimental Pathology,2023,39(02):236-238,241.